Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessMcDonald's Shares Up Nearly 7 percent Since Q3 Results Announcement

McDonald’s Shares Up Nearly 7 percent Since Q3 Results Announcement

Add to Favorite
Added to Favorite


McDonald’s (NYSE:MCD) shares gained nearly 7% since the company’s reported Q3 results on Thursday. EPS came in at $2.68, better than the Street estimate of $2.59. Revenue was $5.87 billion, compared to the Street estimate of $5.72 billion.
According to the analysts at RBC Capital, the quarterly results highlighted the company’s ability to play both offense (e.g., strength of marketing, ongoing delivery demand) and defense (e.g., value and trade-down benefit) amid macro uncertainty.
As valuation becomes more demanding post-Q3 results, analysts expect shares to face a higher degree of scrutiny as Europe and FX headwinds remain. However, the analysts do expect the company to continue to outperform, as they see top-line momentum in the US and abroad, as well as the company’s defensive business model, helping to offset these risks. The analysts raised their price target to $295 from $275, while maintaining their Outperform rating.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Canaan Inc. Gears Up for Earnings Amid Challenges

Projected earnings per share (EPS) of -$0.6 and revenue...

cbdMD, Inc. Q2 Fiscal Year 2024 Financial Results Overview

Significant revenue achievement: cbdMD reported revenue of approximately $4.38...

Ascendis Pharma Faces FDA Review Extension: Insights and Market Impact

The FDA has extended its review period for Ascendis...

Nordson Corporation Quarterly Earnings Preview

Wall Street anticipates an EPS of $2.30 and revenue...